ONCT
Oncternal Therapeutics Inc

9,146
Mkt Cap
$1.56M
Volume
702,150.00
52W High
$0.5266
52W Low
$0.5266
PE Ratio
-0.05
ONCT Fundamentals
Price
$0.5266
Prev Close
$0.6939
Open
$0.70
50D MA
$0.5266
Beta
0.37
Avg. Volume
0.00
P/B
0.17
Loading...
Loading...
Oncternal Therapeutics, Inc. engages in the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Its product pipeline include Zilovertamab, ONCT-216, ONCT-808 and ONCT-534. The company was founded by David F. Hale and James B. Breitmeyer in September 1997 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Oncternal Therapeutics Inc?
What is the 52-week high for Oncternal Therapeutics Inc?
What is the 52-week low for Oncternal Therapeutics Inc?
What is Oncternal Therapeutics Inc stock price today?
What was Oncternal Therapeutics Inc stock price yesterday?
What is the PE ratio of Oncternal Therapeutics Inc?
What is the Price-to-Book ratio of Oncternal Therapeutics Inc?
What is the 50-day moving average of Oncternal Therapeutics Inc?

Latest ONCT News

View
No ONCT news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.